A prospective pilot trial to study alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- 18 Dec 2015 New trial record